Adaptimmune Therapeutics plc (ADAP) slipped -7.41% or -0.4 to $4.93. It is around 193174 shares traded, which is 65.78% compare to the average total volume 293668. The market cap of ADAP is $516.06 million. The year to date change is -11.2%. The 52 week price range is from $3.6 to $14.62. Price of ADAP have changed 9.45% during last week. It have changed -7.14% over last month, -15.66% over last 3 months, -38.24% over last 6 months and -33.04% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ADAP is 5.15. It is 4.46% above current price. The 200-day Moving Averages for ADAP is 9.32. It is 89.05% above current price. The 52-week High is 14.62. It is 196.55% from the current price. The 52-week Low is 3.6. It is -26.98% from current price.
There are some statistics of ADAP. It is has market cap $516.06 million. The share outstanding is 104.57 million. The average volume is 293668. The percent of top 15 Institution holding is 74.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ADAP is -34.29%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ADAP is -28.35%.